Company: BDRX
Filing Date: 2025-05-08
Form Type: POS AM
Source: 0001214659-25-007196
Chunk: 26

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-08
Form: POS AM
Chunk 26
---
 our assets,
tender offer, exchange offer and other business combination transactions, then upon any subsequent exercise of a warrant, the holder thereof
shall have the right to receive, for each Ordinary Share represented by the Depositary Shares that would have been issuable upon such
exercise immediately prior to the occurrence of such fundamental transaction, the number of shares of the successor’s or acquiring
corporation’s securities, if it is the surviving corporation, and any additional consideration receivable as a result of such fundamental
transaction by a holder of the number of Ordinary Shares represented by the Depositary Shares for which the warrant is exercisable immediately
prior to such fundamental transaction.

Transferability. Each
warrant and all rights thereunder are transferable, in whole or in part, upon surrender of the warrant, together with a written assignment
of the warrant subject to applicable securities laws; provided, however, that the Wainwright May Warrants are subject to certain FINRA
transfer restrictions. We do not intend to apply for listing of the warrants on any securities exchange or other trading system.

No Rights as Shareholder Until Exercise. Except as set forth in the warrants, the holders of the warrants do not have any voting
rights, dividends or other rights as a holder of our capital stock until they exercise the warrants.

May 2020 United Kingdom Placing Warrants

On May 22, 2020, we issued 333,333 units, with each unit comprising one new ordinary
share and one warrant to purchase one new Ordinary Share, or a UK Warrant. The exercise price of the UK Warrants is £6.80 per share,
and they expire five years and six months from the issuance date. We also issued UK Warrants to purchase a total of 16,400 Ordinary Shares
to Turner Pope, the placing agent, in connection with the closing of such offering, on the same terms and conditions as the other investors
in the offering.

August 2022 Warrants

On August 3, 2022, we issued
warrants to purchase 16,400 Ordinary Shares to Strand Hanson Limited, in payment for services rendered. The exercise price of such warrants
is £2.70 per share and they expire three years from the issuance date.

February Placement Agent Warrants

The following is a brief summary of the warrants issued to a placement agent issued
in connection with the February Private Placement and is subject in all respects to the provisions contained in the warrant, which, is
filed as an exhibit